The Drug Hunter’s Assistant: Accelerating Drug Discovery With AI
Are The High Expectations Justified?
Executive Summary
The hype around Artificial Intelligence has been deafening in recent years, but real progress can only come when drug discovery culture and regulators catch up with the technology.
You may also be interested in...
Standigm Races AI Rivals To Become Global Discovery Contender
The South Korean AI-driven drug discovery venture is vying with global rivals in the space to show concrete validation of its approaches in partnered projects, while eyeing international expansion and new fundraising, its CEO says.
The Bigger Picture And Global Innovation Hotspots
Focusing too much on the US provides a blinkered view of the industry and prevents access to the myriad opportunities on offer globally.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.